Leading global healthcare knowledge provider, BMJ, and the Office of Health Economics (OHE) are delighted to announce that the award-winning BMJ Impact Analytics, will now be available to researchers at OHE.
Developed in collaboration with pioneering start-up Overton, BMJ Impact Analytics is the most comprehensive tool to track and share the real-world impact of medical and health research. BMJ Impact Analytics helps academic institutions and funders discover where research has been cited in clinical guidance and health policies worldwide. It uniquely shows the impact of research on patient care (citing BMJ's leading decision support tool, BMJ Best Practice) and provides citations in context.
Tim Watson, Director of Marketing & Communications, said, "Understanding the impact of our research on healthcare policy-making globally would be impossible without BMJ Impact Analytics. The scale and depth of information we can access, and the ease with which we can navigate it, is hugely impressive. The value of this tool goes far beyond discovering where we are cited. We see it playing a major role in identifying future collaborators as well as additional avenues for sharing our research. All of this will enhance our ability to make meaningful contributions to the field of healthcare research and positively impact patient care worldwide."
This agreement marks a significant milestone in our journey. With BMJ Impact Analytics, we are poised to equip OHE with powerful insights on the real-world impact of health research, helping advance healthcare policies globally."
Anca Babor, Director of Customers and Markets at BMJ
Study reveals AI's potential and pitfalls in medical diagnosis